Y-Intercept (HK)’s Sionna Therapeutics SION Stock Holding History

Y-Intercept (HK)’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.56M	Buy	+1,056,885	New	+$24.3M	0.12%	196

Other funds holding SION

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Y-Intercept (HK)'s SION Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Sionna Therapeutics (SION) in Q3 2026: 1,056,885 shares worth $5.56M. The stake represents 0.12% of the portfolio and ranks #196 among its holdings.

11 funds tracked by Wall St. Rank hold SION as of Q3 2026.

Y-Intercept (HK) held 1,056,885 shares of Sionna Therapeutics worth $5.56M as of Q3 2026.
Sionna Therapeutics was a new Y-Intercept (HK) position in Q3 2026.
Sionna Therapeutics made up 0.12% of Y-Intercept (HK)'s portfolio in Q3 2026, its #196 holding.
11 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.